OLED Stock Cash Flow Statements

Universal Display Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Universal Display Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2005-06-30	2004-03-31

cash flows from operating activities:
net income	67,264,000	64,444,000	46,019,000	66,870,000	52,337,000	56,853,000	61,978,000	51,516,000	49,678,000	39,839,000	65,134,000	53,455,000	41,502,000	49,970,000	45,876,000	46,109,000	40,541,000	51,687,000	53,902,000	40,500,000	815,000	38,155,000	26,428,000	36,962,000	43,440,000	31,474,000	19,249,000	22,818,000	10,814,000	5,959,000	32,813,000	13,520,000	47,187,000	10,365,000	25,819,000	-1,500,000	21,802,000	1,949,000	18,088,000	7,047,000	-11,771,000	1,314,000	13,126,000	4,285,000	57,886,000	5,542,000	15,382,000	-4,758,000	10,964,000	-1,221,000	5,733,883	5,989,426	3,312,700	-11,880,856	-5,316,414	-7,186,570	-4,436,095	-2,978,331	-3,847,696	-4,672,847	-6,415,178	-5,569,599	-4,437,578	-5,302,983	-5,205,790	-4,193,385	-3,256,104	-2,960,565	-5,175,371	-4,583,801		-97,018,319
adjustments to reconcile net income to net cash from operating activities:
depreciation	6,854,000	6,548,000	6,452,000	6,396,000	6,476,000	6,616,000	7,281,000	6,921,000	6,711,000	6,496,000	6,833,000	6,453,000	5,902,000	5,627,000	5,497,000	5,242,000	4,966,000	4,263,000	4,070,000	3,864,000	3,668,000	3,615,000	3,498,000	3,159,000	3,041,000	2,758,000	2,518,000	1,672,000	2,250,000	2,172,000	1,281,000	1,240,000	1,188,000	1,210,000	1,268,000	1,163,000	937,000	902,000	863,000	784,000	737,000	702,000	578,000	562,000	551,000	508,000	476,000	509,000	509,000	418,000	358,841	358,708	361,696	371,901	377,537	384,481	431,241	513,557	516,800	516,700	518,654	517,472	521,910	494,944	480,393	445,937	426,687	427,370	454,040	466,139	-5,320,356	6,058,470
amortization of intangibles	4,548,000	4,545,000	4,552,000	4,551,000	4,549,000	4,548,000	4,551,000	4,557,000	3,994,000	2,891,000	2,897,000	3,562,000	5,502,000	5,498,000	5,504,000	5,505,000	5,497,000	5,488,000	5,495,000	5,494,000	5,490,000	5,490,000	5,493,000	5,493,000	5,490,000	5,486,000	5,483,000	5,493,000	5,495,000	5,491,000	5,498,000	5,498,000	5,495,000	5,492,000	5,453,000	5,460,000	2,829,000	2,750,000	2,750,000	2,749,000	2,750,000	2,750,000	2,749,000	2,750,000	2,749,000	2,741,000	2,741,000	2,742,000	14,000	15,000	14,655	14,655	14,655	4,884	0	386,736	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	423,768	-5,122,247	5,969,783
amortization of premium and discount on investments	-1,025,000	-1,471,000	-1,469,000	-1,654,000	-2,040,000	-2,236,000	-2,167,000	-2,591,000	-3,248,000	-3,597,000	-2,992,000	-2,442,000	-756,000	-271,000	-144,000	-101,000	-58,000	-70,000	-667,000	-1,013,000	-1,275,000	-2,005,000	-2,115,000	-1,378,000	-1,409,000	-1,741,000	-1,940,000	-1,862,000	-1,363,000	-966,000	-816,000	-795,000	-698,000	-562,000	-514,000	-515,000	-504,000	-297,000	-218,000	-194,000	-150,000	-135,000	-126,000	-136,000	-122,000	-117,000	-103,000	-116,000	-199,000	-238,000	-291,282	-316,797	-102,452	-64,039	-50,846	-41,723	-36,549	-43,619	-69,494	-89,625	-122,059	-144,887	-101,738	-115,431	-389,034	-438,296	-122,307	-72,955	-70,701	-45,650
stock-based compensation	9,343,000	7,076,000	6,220,000	5,289,000	9,349,000	9,174,000
deferred income tax benefit	-1,501,000	-3,091,000			-3,466,000	-3,936,000			-6,846,000	-5,936,000									-2,204,000	-1,906,000															-1,632,000	-100,000	4,995,000	-169,000		307,000	3,650,000	334,000		1,904,000
retirement plan expense, net of benefit payments	424,000	423,000	423,000	423,000	632,000	330,000	782,000	950,000	615,000	782,000
decrease (increase) in assets:
accounts receivable	-7,480,000	-25,915,000	-25,955,000	36,693,000	-4,802,000	20,266,000	-17,658,000	-12,802,000	-16,713,000	-13,000	-14,471,000	-3,260,000	30,014,000	2,692,000	-11,404,000	3,394,000	-8,302,000	-9,066,000	17,089,000	-30,852,000	14,094,000	-22,140,000	5,322,000	1,178,000	-14,828,000	-8,995,000	78,000	-7,624,000	-12,815,000	29,587,000	-9,099,000	-3,554,000	-3,381,000	-11,327,000	-2,518,000	-3,022,000	2,882,000	3,863,000	3,621,000	-10,972,000	786,000	3,911,000	32,000	-1,607,000	2,128,000	-3,334,000	-3,924,000	-1,870,000	-872,000	2,019,000	1,034,756	-5,220,048	-555,844	1,262,485	-2,551,533	-810,960	-1,486,083	944,958	-1,457,910	-125,582	52,595	637,086	-657,683	-63,096	585,103	80,648	94,422	-652,165	-66,822	342,412	1,521,684	-1,108,683
inventory	-10,801,000	-14,460,000	-6,980,000	-4,115,000	1,062,000	2,890,000	5,611,000	-5,551,000	-1,610,000	8,975,000	-658,000	-16,239,000	-22,999,000	-9,164,000	-14,171,000	-17,773,000	-3,681,000	-10,498,000	-7,799,000	228,000	-10,455,000	-10,726,000	-7,965,000	2,367,000	3,972,000	1,735,000	-3,554,000	-14,033,000	-2,405,000	-17,373,000	-3,532,000	-8,296,000	-7,769,000	646,000	-1,211,000	470,000				3,281,000				-9,170,000	-2,742,000	821,000	409,000	1,936,000	-2,997,000	-1,731,000	-1,612,109								42,059	-41,370			0	0			-38,956	0	23,056	5,333		-27,327
other current assets	-20,177,000	400,000	16,068,000	6,086,000	-43,251,000	-2,113,000	-3,921,000	-49,691,000	3,440,000	8,598,000	-21,288,000	9,475,000	-9,505,000	-3,525,000	36,039,000	-7,914,000	-11,112,000	5,400,000	9,351,000	3,113,000	-13,673,000	7,706,000	-10,636,000	-1,786,000	-2,993,000	177,000	4,976,000	8,942,000	-5,033,000	-4,025,000	-1,049,000	-2,036,000	-1,415,000	616,000	1,107,000	-1,803,000	-878,000	-2,296,000	2,136,000	250,000	-1,120,000	703,000	8,979,000	-261,000	-248,000	-145,000	1,390,000	-3,703,000	-1,430,000	-827,000	69,675	1,124,546	-1,158,719	305,024	-1,364,060	-168,112	-83,483	38,655	91,880	57,985	-76,568	-20,988	186,992	91,357	-157,851	90,525	72,005	-6,892	-99,368	-33,409		128,519
other assets	-5,664,000	-2,568,000	1,429,000	-10,841,000	3,537,000	2,907,000	-3,842,000	627,000	2,150,000	5,515,000	23,689,000	-5,240,000	-1,966,000	9,488,000	-2,599,000	-18,535,000	-7,872,000	-7,133,000	-4,760,000	-2,779,000	-2,697,000	-3,245,000	-3,032,000	-4,413,000	-2,880,000	-2,966,000	-26,153,000	140,000	-37,732,000	-177,000	-257,000	-30,000	-102,000	92,000	116,000	120,000	103,000	-472,000	58,000	113,000	60,000	20,000	83,000	-14,000	40,000	-7,000	-16,000	18,000	-5,000	15,000	13,420	10,851	9,225	-115,931	49,582	4,821	-25,375	-18,281	10,482	-850	-153,417	-13,719	2,500	2,500	2,500	2,500	2,500	12,500	2,500	-7,500		-121,773
increase in liabilities:
accounts payable and accrued expenses	18,040,000	-13,408,000	952,000	-2,962,000	20,344,000	-7,977,000	4,079,000	17,619,000	6,465,000	-24,116,000	-3,879,000	14,343,000	-2,865,000	-4,261,000	5,213,000	13,725,000	4,100,000	-21,136,000	11,328,000	699,000	9,008,000	-29,340,000	17,343,000	272,000	10,018,000	-12,117,000	1,124,000	13,562,000	-8,682,000	-4,441,000	12,516,000	5,820,000	6,367,000	-8,283,000	9,496,000	491,000	3,509,000	-9,134,000	-402,000	366,000	9,410,000	-8,584,000	6,174,000	-5,033,000	3,349,000	451,000	6,651,000	-6,837,000	3,886,000	-1,987,000	1,467,861	3,470,371	1,583,337	253,119	52,752	871,135	1,185,884	278,171	-1,607,897	974,189	921,250	-498,481	-1,184,063	1,149,001	915,678	-259,176	-1,290,162	-50,460	433,501	-909,422		2,844,997
other current liabilities	-20,020,000	16,867,000	3,246,000	164,000	-14,927,000	12,786,000	2,705,000	-3,375,000	-33,685,000	12,874,000	21,460,000	2,800,000	-9,150,000	5,807,000	3,534,000	1,107,000	-1,870,000	-666,000	3,489,000	-167,000	-3,753,000	3,114,000	-10,770,000	-1,149,000	2,992,000	3,744,000	5,795,000	-9,000	0	-25,000	-1,149,000	53,000	-602,000	-219,000	4,367,000	-261,000	-334,000	590,000	63,000	51,000	-3,000	-55,000	-382,000	52,000	10,000	-925,000			206,000	-1,000	-1,139
deferred revenue	13,109,000	-8,491,000	-16,158,000	-20,747,000	38,067,000	-27,270,000	-15,968,000	27,545,000	-7,120,000	-8,616,000	-226,164,000	39,985,000	47,085,000	45,891,000	41,463,000	67,205,000	39,816,000	53,000,000	48,169,000	68,517,000	31,998,000	43,685,000	43,472,000	45,636,000	35,133,000	33,080,000	30,699,000	35,517,000	34,092,000	30,331,000	6,539,000	1,358,000	399,000	106,000	64,000	1,046,000	0	2,250,000	401,000	-1,000	2,030,000	46,382,000	2,000,000	101,000	636,000	755,000	1,332,000	44,000	293,000	1,042,000	1,254,601	1,685,000	345,000	1,300,000	1,864,601	-520,922	450,000	125,000	1,364,860	1,079,007	-385,773	-426,567	914,656	1,712,634	-150,000	-111,371	-391,183	-116,051	-281,395	750,000	550,977	67,204
other liabilities	-978,000	-337,000	-1,345,000	-819,000	-854,000	-682,000	-525,000	-3,057,000	-959,000	-486,000	-42,548,000	5,526,000	2,246,000	2,384,000	-11,797,000	17,478,000	7,520,000	6,935,000	-2,067,000	3,038,000	3,422,000	2,994,000	17,465,000	806,000	-3,789,000	3,132,000	5,559,000	3,000
net cash from operating activities	51,936,000	30,562,000	34,713,000	79,858,000	67,013,000	72,156,000	37,070,000	60,309,000	9,777,000	47,621,000	2,641,000	38,044,000	33,522,000	52,608,000	56,779,000	75,210,000	29,620,000	29,496,000	72,965,000	43,797,000	26,284,000	5,746,000	56,166,000	53,867,000	49,829,000	34,050,000	26,840,000	45,004,000	11,137,000	38,815,000	62,104,000	14,632,000	54,985,000	1,644,000	40,004,000	4,103,000	36,021,000	210,000	32,991,000	5,443,000	28,198,000	46,980,000	28,493,000	-6,231,000	22,411,000	7,041,000	26,433,000	-10,898,000	11,213,000	-2,012,000	8,614,730	5,954,554	222,645	1,617,498	773,609	-2,215,766	-2,315,133	-442,848	-2,778,445	-3,033,609	-4,292,983	-4,505,171	-983,487	-522,949	-2,906,327	-3,372,401	-1,646,332	-2,575,906	-3,579,712	-3,294,814		-39,905,736
capex	-15,722,000	-7,572,000	-16,552,000	-12,117,000	-16,054,000	-7,362,000	-7,793,000	-23,993,000	-18,996,000	-8,332,000	-12,565,000	-6,138,000	-12,051,000	-8,674,000	-15,342,000	-11,043,000	-10,337,000	-9,965,000	-9,354,000	-8,691,000	-7,321,000	-4,093,000	-5,104,000	-5,830,000	-6,021,000	-13,634,000	-4,790,000	-6,791,000	-6,170,000	-4,150,000	-6,582,000	-15,101,000	-6,845,000	1,297,000	-2,939,000	-1,946,000	-2,109,000	-173,000	-453,000	-1,637,000	-1,235,000	-2,636,000	-1,939,000	-1,579,000	0	-1,765,000	-1,886,000	-549,000	-252,000	-1,802,000	0	-698,072	-1,034,966	-475,365	0	-74,233	-55,076	-89,300	0	-76,486	-30,452	-95,801	0	-689,754	0	-219,578	-564,266	-341,471	-144,255	-175,865		-8,420,286
free cash flows	36,214,000	22,990,000	18,161,000	67,741,000	50,959,000	64,794,000	29,277,000	36,316,000	-9,219,000	39,289,000	-9,924,000	31,906,000	21,471,000	43,934,000	41,437,000	64,167,000	19,283,000	19,531,000	63,611,000	35,106,000	18,963,000	1,653,000	51,062,000	48,037,000	43,808,000	20,416,000	22,050,000	38,213,000	4,967,000	34,665,000	55,522,000	-469,000	48,140,000	2,941,000	37,065,000	2,157,000	33,912,000	37,000	32,538,000	3,806,000	26,963,000	44,344,000	26,554,000	-7,810,000	22,411,000	5,276,000	24,547,000	-11,447,000	10,961,000	-3,814,000	8,614,730	5,256,482	-812,321	1,142,133	773,609	-2,289,999	-2,370,209	-532,148	-2,778,445	-3,110,095	-4,323,435	-4,600,972	-983,487	-1,212,703	-2,906,327	-3,591,979	-2,210,598	-2,917,377	-3,723,967	-3,470,679		-48,326,022
cash flows from investing activities:
purchases of property and equipment	-14,477,000	-13,059,000	-12,677,000	-13,626,000	-9,128,000	-7,206,000	-7,584,000	-24,934,000	-18,176,000	-9,098,000	-11,378,000	-9,783,000	-10,585,000	-10,751,000	-13,665,000	-8,828,000	-10,730,000	-9,938,000	-8,778,000	-7,409,000	-7,022,000	-4,782,000	-4,742,000	-4,995,000	-7,039,000	-13,283,000	-4,466,000	-7,505,000	-4,687,000	-8,733,000	-6,582,000	-13,504,000	-9,086,000	-631,000	-2,939,000	-2,199,000	-1,646,000	-516,000	-453,000	-1,504,000	-1,196,000	-1,950,000	-1,939,000	-1,263,000																						-219,578	-564,266	-341,471	-144,255	-175,865
purchases of investments	-153,179,000	-38,772,000	-256,899,000	-163,192,000	-74,810,000	-99,947,000	-228,099,000	-187,956,000	-49,841,000	-65,207,000	-237,227,000	-176,847,000	-263,004,000	-24,915,000	-369,840,000	-78,389,000	-189,731,000	-4,220,000	0	-199,921,000	-255,640,000	-148,592,000	-283,848,000	-284,411,000	-198,124,000	-165,471,000	-127,804,000	-240,274,000	-137,336,000	-123,375,000	-138,019,000	-201,040,000	-85,088,000	-170,136,000	-70,017,000	-55,034,000	-131,297,000	-193,929,000	-238,204,000	-186,152,000	-215,563,000	-51,957,000	-107,050,000	-118,236,000																						-30,074,485	-33,991,201	-9,796,618	-8,946,902	-8,601,461		-54,884,893
proceeds from sale and maturity of investments	75,000,000	110,000,000	272,307,000	103,148,000	54,650,000	42,970,000	227,758,000	155,500,000	75,876,000	115,031,000	165,584,000	141,342,000	111,290,000	50,240,000	112,744,000	15,240,000	0	100,000,000
net cash from investing activities	-92,656,000	58,169,000	2,731,000	-73,670,000	-29,288,000	-64,183,000	-7,925,000	-57,890,000	-58,153,000	40,675,000	-82,969,000	-50,037,000	-162,299,000	14,562,000	-270,761,000	-71,977,000	-200,557,000	85,544,000	401,337,000	-6,780,000	-100,327,000	97,026,000	-155,540,000	-136,656,000	62,587,000	-9,105,000	85,212,000	-43,929,000	-76,722,000	14,438,000	2,883,000	-52,855,000	-35,486,000	-40,120,000	40,618,000	-19,686,000	-73,530,000	14,126,000	-25,906,000	-25,054,000	-44,577,000	36,969,000	-14,397,000	-16,876,000	-20,649,000	-21,363,000	8,633,000	-21,396,000	3,707,000	37,324,000	36,401,205	-9,836,627	-195,488,598	-14,865,428	3,906,480	-2,466,264	1,103,556	-14,373,589	14,203,717	2,818,772	7,923,545	-16,920,046	-24,358,009	15,158,502	29,172,014	-19,372,063	-27,206,467	-455,089	-576,157	-4,432,326	38,772,422	-23,775,206
cash flows from financing activities:
proceeds from issuance of common stock	495,000	579,000	444,000	589,000	548,000	639,000	480,000	561,000	453,000	518,000	323,000	400,000	444,000	403,000	371,000	349,000	439,000	348,000	307,000	279,000	331,000	259,000	231,000	213,000	241,000	204,000	182,000	180,000	235,000	201,000	205,000	180,000	190,000	159,000	122,000	115,000	103,000	99,000				90,000																														73,897,512
payment of withholding taxes related to stock-based compensation to employees	-44,000	-9,398,000	-135,000	-922,000	-271,000	-7,058,000	-311,000	-466,000	-248,000	-7,181,000	-59,000	-306,000	-948,000	-7,896,000	-69,000	-1,862,000	-3,384,000	-9,634,000	-101,000	-1,128,000	-8,349,000	-4,816,000	-60,000	-1,448,000	-8,715,000	-5,757,000	-22,000	-567,000	-5,199,000	-5,832,000		-829,000	-4,960,000	-3,541,000		-46,000			-24,000	-33,000				-10,000
cash dividends paid	-21,400,000	-21,419,000	-18,332,000	-19,152,000	-19,158,000	-19,527,000	-16,652,000	-16,661,000	-16,653,000	-16,769,000	-14,256,000	-14,247,000	-14,247,000	-14,246,000	-9,484,000	-9,477,000	-9,483,000	-9,487,000	-7,116,000	-7,114,000	-7,117,000	-7,098,000	-4,711,000	-4,712,000	-4,713,000	-4,717,000	-2,828,000	-2,827,000	-2,828,000	-2,831,000	-1,412,000	-1,412,000	-1,414,000	-1,414,000
net cash from financing activities	-20,949,000	-30,238,000	-18,023,000	-19,485,000	-18,881,000	-25,946,000	-16,483,000	-16,566,000	-16,448,000	-23,432,000	-13,992,000	-14,153,000	-14,751,000	-21,739,000	-9,182,000	-10,990,000	-12,428,000	-18,773,000	-6,910,000	-7,963,000	-15,135,000	-11,655,000	-4,540,000	-5,947,000	-13,187,000	-10,919,000	-2,668,000	-3,214,000	-7,792,000	-8,939,000	-1,300,000	-2,062,000	-6,178,000	-4,772,000	4,327,000	69,000	-2,652,000	-1,758,000	472,000	316,000	441,000	-4,178,000	-6,069,000	-15,056,000	1,739,000	705,000	100,000	-8,093,000	433,000	-2,861,000	-345,148	5,766,450	2,400,259	250,984,837	7,486,023	1,130,485	5,412,219	-331,046	667,069	942,200	186,373	-831,877	-752,055	239,477	572,335	1,575,848	2,117,659	2,141,204	41,127,318	1,153,785	-106,366,339	107,229,901
increase in cash and cash equivalents	-61,669,000	58,493,000			18,844,000	-17,973,000			-64,824,000	64,864,000				45,431,000	-223,164,000	-7,757,000	-183,365,000	96,267,000	467,392,000	29,054,000	-89,178,000	91,117,000	-103,914,000	-88,736,000	99,229,000	14,026,000				44,314,000				-43,248,000	84,949,000	-15,514,000	-40,161,000	12,578,000	7,557,000	-19,295,000	-15,938,000	79,771,000					35,166,000	-40,387,000	15,353,000	32,451,000	44,670,787	1,884,377	-192,865,694	237,736,907					12,092,341	727,363			-26,093,551	14,875,030			-26,735,140	-889,791			-29,672,767	43,548,959
cash and cash equivalents, beginning of period	0	98,980,000		0	0	91,985,000		0	0	93,430,000		0	0	311,993,000		0	0	630,012,000		0	0	131,627,000		0	0	211,022,000		0	0	132,840,000		0	0	139,365,000		0	0	97,513,000		0	0	45,418,000		0		0	0	85,923,000	0	111,795,000		0	0	20,368,852		0	0	22,701,126		0	0	28,321,581		0	0	33,870,696		0	0	31,097,533
cash and cash equivalents, end of period	-61,669,000	157,473,000		-13,297,000	18,844,000	74,012,000		-14,147,000	-64,824,000	158,294,000		-26,146,000	-143,528,000	357,424,000		-7,757,000	-183,365,000	726,279,000		29,054,000	-89,178,000	222,744,000		-88,736,000	99,229,000	225,048,000		-2,139,000	-73,377,000	177,154,000		-40,285,000	13,321,000	96,117,000		-15,514,000	-40,161,000	110,091,000		-19,295,000	-15,938,000	125,189,000		-38,163,000		-13,617,000	35,166,000	45,536,000	15,353,000	144,246,000		1,884,377	-192,865,694	258,105,759		-3,551,545	4,200,642	7,553,643		727,363	3,816,935	6,064,487		14,875,030	26,838,022	12,702,080		-889,791	36,971,449	24,524,178	-10,742,186	43,548,959
supplemental disclosures:
unrealized gain on available-for-sale securities	-319,000	1,320,000	-3,706,000	7,093,000	-310,000	-2,666,000		1,456,000	-1,354,000	3,202,000					-256,000	-4,000	31,000	-66,000	-569,000	-791,000	-1,138,000	2,380,000	14,000	35,000	132,000	60,000	68,000	55,000	150,000	69,000								-233,000				22,000							65,000	-104,000						32,069	-6,630	-33,511				14,768		28,395	-69,222	83,589		27,929	-17,519	55,754
common stock issued to board of directors and scientific advisory board that was earned and accrued for in a previous period	0	300,000	0	0	0	300,000	0	0	0	300,000	0	0	0	300,000	0	0	0	300,000	0	0	0	300,000	0	0	0	300,000	0	0	0	300,000		0	0	300,000		0				0				0
net change in accounts payable and accrued expenses related to purchases of property and equipment	-1,245,000	5,487,000	-3,875,000	1,509,000	-6,926,000	-156,000	-209,000	941,000	-820,000	766,000	-1,187,000	3,645,000	-1,466,000	2,077,000	-1,677,000	-2,215,000	393,000	-27,000	-576,000	-1,282,000	-299,000	689,000	-362,000	-835,000	1,018,000	-351,000	-324,000	714,000	-1,483,000	4,583,000		-1,597,000	2,241,000	1,928,000		253,000	-463,000	343,000		-133,000	-39,000	-686,000		-316,000
cash paid for income taxes, net of refunds	43,350,000	2,266,000	11,201,000	13,509,000	42,178,000	5,085,000
impairment of property and equipment and right-of-use asset due to ovjp restructuring
impairment of minority investments
purchase of intangibles																																			0	44,000																0	0	-439,644																		-25,750
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
deferred income tax (benefit) expense											-19,070,000	-5,594,000	-902,000	-1,380,000									-3,143,000	-1,415,000	-626,000	-592,000								1,049,000
purchases of intangibles								-500,000	-66,012,000	-51,000		-4,749,000	0	-12,000		0	-96,000	-298,000		0				0	0	-401,000
decrease in cash and cash equivalents							12,662,000					-26,146,000																-2,139,000				-40,285,000											8,027,000												12,166,112	-3,551,545	4,200,642	-15,147,483				-22,257,094				-21,168,616				-6,573,355
stock-based compensation to employees							4,976,000	6,880,000	6,487,000	3,992,000	5,852,000	8,246,000	8,197,000	6,085,000	12,025,000	8,222,000	9,424,000	5,200,000	6,824,000	6,889,000	7,183,000	5,735,000	5,451,000	3,591,000	3,496,000	3,610,000	2,735,000	3,534,000	3,387,000	2,776,000	3,817,000	3,063,000	2,263,000	3,141,000	3,143,000	2,830,000	2,571,000	2,830,000	2,414,000	2,720,000	2,324,000	1,715,000	1,945,000	1,807,000
stock-based compensation to board of directors and scientific advisory board							510,000	423,000	418,000	423,000	445,000	347,000	344,000	430,000	352,000	348,000	374,000	330,000	514,000	425,000	454,000	254,000	422,000	242,000	368,000	516,000	1,130,000	1,231,000	1,106,000	897,000	719,000	562,000	619,000	709,000	442,000	382,000	483,000	408,000	473,000	159,000	293,000	366,000	266,000	266,000	212,000	203,000	170,000	224,000	224,000	213,000	124,688	534,158	188,637	529,480	671,729	276,318	234,962	149,703	433,994	144,789	104,987	71,524	399,325	112,078	116,985	116,628	435,714	90,086	119,378	109,533
the following non-cash activities occurred:
unrealized loss on available-for-sale securities											1,611,000	-2,616,000	-2,064,000	-5,031,000																				-23,000	-463,000	125,000				1,000								-3,000					216,911	-10,550						27,736
deferred income tax expense															-2,478,000	2,768,000	943,000	515,000				940,000						-3,492,000	19,240,000	72,000	17,592,000	-604,000
cash paid for income tax								21,283,000
retirement plan expense											1,278,000	1,280,000	1,359,000	1,359,000	2,199,000	2,219,000	2,229,000	2,228,000	1,414,000	1,414,000	1,414,000	1,414,000	1,439,000	1,439,000	1,439,000	1,501,000		1,126,000	1,126,000	1,126,000		1,126,000	1,083,000	1,005,000
amortization of deferred revenue and recognition of unbilled receivables												-76,333,000	-61,090,000	-64,106,000	-59,826,000	-54,730,000	-53,345,000	-57,648,000	-71,489,000	-53,864,000	-18,133,000	-40,511,000	-34,289,000	-37,137,000	-36,966,000	-26,976,000	-16,580,000	-23,059,000
change in excess inventory reserve												1,680,000	604,000	84,000	1,496,000	941,000	450,000	667,000	306,000	197,000	0	611,000	1,783,000	0	3,931,000	224,000
repurchase of common stock																							0	0	0	-649,000	0	0	0	-477,000													-7,000,000	-15,500,000	0	0	0	-5,456,000
deferred income taxes
proceeds from sale of investments																				200,550,000	162,360,000	250,400,000	133,050,000	152,750,000	267,750,000	170,050,000	217,482,000	203,850,000	65,301,000	146,546,000	147,484,000	161,689,000	58,688,000	130,647,000	113,791,000	70,666,000	155,446,000	208,571,000	212,751,000	162,602,000	172,182,000	90,876,000	94,592,000	102,623,000	58,110,000	79,929,000	93,729,000	81,364,000	41,914,000	178,638,000													10,579,000	27,334,000	49,902,000	10,922,000	7,349,000	9,683,000	8,515,000	4,345,000	-14,748,723	39,555,723
change in earnout liability recorded for adesis acquisition																																40,000
proceeds from the exercise of common stock options																															9,000	-1,000	6,000	24,000	3,000	0	31,000	151,000	405,000	257,000	670,000	702,000		337,000		619,000
common stock issued to employees that was earned and accrued for in a previous period																																0	0	174,000		0				0				0
inventory write-down																											2,585,000												0	0
excess tax benefits from share-based payment arrangements
retirement plan benefit expense																																			961,000	1,022,000	953,000	1,029,000	921,000	921,000	920,000	592,000	422,000	419,000	415,000	416,000	417,000	417,000	389,000	388,000	381,718	381,718	381,718	381,718
purchase of business, net of cash acquired																																			-217,000
earnout liability recorded for adesis acquisition																																		294,000	160,000
excess tax benefits accrued for in other current liabilities
amortization of deferred revenue																														-12,589,000	-3,916,000	-2,333,000	-2,183,000	-2,690,000	-2,125,000	-1,680,000	-1,569,000	-2,032,000	-1,963,000	-2,138,000	-3,716,000	-1,177,000	-449,000	-2,156,000	-2,598,000	-1,447,000	-1,157,000	-678,000	-920,000	-917,000	-1,040,651	-754,960	-774,332	-705,121
change in earnout liability recorded for adesis acquistion
decrease (increase) in assets, net of effect of acquisition:
payment of withholding taxes on stock-based compensation to employees
common stock issued to the board of directors and scientific advisory board earned and accrued in a previous period
common stock issued to employees earned and accrued in a previous period
net change in accruals for purchases of property and equipment
excess tax benefits accrued in other current liabilities
unrealized (gain) loss on available-for-sale securities
increase in liabilities, net of effect of acquisition:
inventories																																						-1,961,000				-1,858,000
payment of withholding taxes related to stock-based employee compensation																																						-2,008,000				-4,970,000			-278,000	-5,000	-189,000	-2,796,000	-35,000	-3,473,000	-474,033	-19,043	-41,821	-3,937,652	-19,050	-15,101	-16,034	-1,116,387	-10,031	-14,052	-12,597	-831,877
common stock issued to board of directors and scientific advisory board that was earned in a previous period																																						300,000				300,000				0	0	300,000	0	328,000		0	0	299,943		0	0	314,181		0	0	309,802		0	0	299,968		0
common stock issued to employees that was accrued for in a previous period																																						1,105,000				967,000
increase in assets:
additions to intangibles																																													8,000	-260,000	-38,000	-69,000
proceeds from issuance of common stock under espp																																								92,000				117,000
proceeds from the exercise of common stock options and warrants																																																66,000	402,000	541,000	59,994	5,740,013	2,422,840	5,119,944	7,451,007	1,083,618	5,361,262	722,682	599,803	903,365			19,500	239,477	572,335	1,575,848	2,117,659	2,170,204	3,098,295	1,153,785	-17,169,137	18,032,699
stock-based employee compensation																																													1,563,000	1,579,000	1,761,000	1,174,000	1,151,000	800,000	1,102,387	1,119,388	1,111,930	1,038,968	2,651,012	711,000	728,568	463,133	1,736,250	430,559	438,122	551,489	2,767,706	299,437	243,920	352,512	1,930,216	248,006	277,076	278,611
stock-based non-employee compensation																																																			3,426	965	1,461	473	3,914	0	2,460	40,848	0	493	4,520	1,998	991	0	0	4,119	13,839	0
non-cash expense under materials and license agreements
loss on stock warrant liability																																																			0	-239,562			4,845,439	3,362,441			-90,025	1,001,612
purchase of property and equipment																																														-1,765,000	-1,886,000	-549,000	-252,000	-1,802,000		-698,072	-1,034,966	-475,365		-74,233	-55,076	-89,300		-76,486	-30,452	-95,801		-689,754
purchase of investments																																														-99,267,000	-83,172,000	-102,142,000	-37,937,000	-139,512,000														-11,485,744
proceeds from the issuance of common stock																																														91,000	84,000	93,000	66,000	71,000		45,480	19,240	249,802,545		61,968	66,991	62,659										-29,000
common stock issued to employees that was accrued for in a previous period, net of shares withheld for taxes																																														0	0	282,000	0	252,000		0	0	1,113,483		0	0	929,552
property and equipment purchases included in accounts payable
property, equipment and intangible invoices included in accounts payable																																															-18,000	909,000
purchases of short-term investments
proceeds from sale of short-term investments																																																			83,990,000	27,227,000	22,104,000	23,395,654	23,478,000	17,670,001	17,845,000	20,939,983	17,930,000	8,556,000	23,489,000	19,655,000
non-cash expense under a materials agreement																																																				0	0	9,181		338,961	313,764	243,459
fair value of stock warrant liability reclassified to shareholders’ equity upon exercise																																																				4,348,616
1.
purchase of short-term investments																																																				-36,365,555	-216,557,632	-37,346,073		-20,062,032	-16,686,368	-35,224,272		-5,660,742	-15,535,003	-36,479,245
common stock issued for royalties that was earned in a previous period																																																								0	0	81,273		0	0	81,954		0	0	66,403		0
gain on stock warrant liability																																																						8,926,212				-713,243				-173,242
fair value of stock warrant liability reclassified to shareholders' equity upon exercise																																																						6,476,182
amortization of deferred license fees and deferred revenue																																																							-1,237,225	0	-2,942,704	-710,626	-643,968
deferred license fees																																																							157,878	-165,455	0	800,000			-170,399	-170,400	-170,401	348,337	-127,089	-128,711	-127,900	-127,899	-127,901	-127,900	-3,158,666	4,366,667
retirement plan benefit liability																																																								342,083
common stock issued to employees that was earned in a previous period, net of shares withheld for taxes																																																												-11,556
common stock issued to non-employee that was earned in a previous period																																																																0
non-cash charges to statement of operations:
non-cash expense under a development agreement																																																													272,926	309,375		324,505	316,134	241,901	181,129	209,351	499,030	37,072
common stock issued to employees that was earned in a previous period																																																														845,745		-12,842	-24,587	904,939		-5,673
non-cash expense under development and license agreements
net proceeds from issuance of common stock
common stock issued under a development agreement that was earned in a previous period																																																																				0
common stock issued to non-employees that was earned in a previous period																																																																		991
repayment of loan
restricted cash
supplemental disclosure of cash flow information
cash paid for interest
common stock issued to board of directors and scientific advisory board that were earned in a previous period																																																																						260,000
common stock issued to employees that were earned in a previous period																																																																						969,257
common stock issued for royalties that were earned in a previous period																																																																						499,993
cash flows used in operating activities:
proceeds from loan
principal payments on capital lease																																																																								-17,391
issuance of common stock to employees
issuance of common stock options and warrants for services																																																																								1,689,481
issuance of common stock, options and warrants in connection with development agreement
issuance of common stock to board of directors and scientific advisory board
common stock, options and warrants in connection with development agreement
common stock to employees
common stock and options to board of directors and scientific advisory board
common stock options and warrants for services
payment of loan
amortization of discounts on convertible promissory note																																																																								14,734,168
amortization of premium on investments																																																																								129,003
issuance of common stock and warrants in connection
with amended research and license agreements																																																																								3,120,329
issuance of common stock in connection with
employee bonus																																																																								790,521
issuance of redeemable common stock, common stock options and
warrants in connection with the ppg development agreement																																																																								15,458,319
issuance of common stock, options and warrants to board of directors
and scientific advisory board																																																																								2,591,089
issuance of common stock in connection with license agreement																																																																								71,816
acquired in-process technology																																																																								350,000
purchases of equipment																																																																								-8,420,286
proceeds from issuance of preferred stock																																																																								9,137,079
proceeds from issuance of convertible promissory
notes and equity instruments																																																																								15,000,000
repayment of convertible promissory notes																																																																								-8,819,997

We provide you with 20 years of cash flow statements for Universal Display stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Universal Display stock. Explore the full financial landscape of Universal Display stock with our expertly curated income statements.

The information provided in this report about Universal Display stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.